Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06057376 · ClinicalTrials.gov registry record · NA
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
A NA study of Carbohydrate Intolerance, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06057376: Recruiting NA study of Carbohydrate Intolerance, sponsored by Oregon Health and Science University.
NCT06057376 is a NA study of Carbohydrate Intolerance that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06057376, a NA study of Carbohydrate Intolerance, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
In this project we want to assess impact of dietary fructose as a simple sugar intolerance on abdominal pain and compare a low FODMAP diet versus an added sugar elimination diet effectiveness on symptoms but also impact on microbiome and its metabolome.
Conditions Studied
Interventions
- OTHER Low-FODMAP diet group (LFD)
- OTHER Low Sugar diet group (LAS)
Study Locations (1)
Oregon
- Oregon Health and Science University - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-10-26 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT06057376 shows while recruiting
NCT06057376 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Carbohydrate Intolerance appearing as the primary indexed condition, and to 2 interventions - of which Low-FODMAP diet group (LFD) is the first listed.
NCT06057376 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06057376 about?
NCT06057376 is a clinical study titled "Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance". In this project we want to assess impact of dietary fructose as a simple sugar intolerance on abdominal pain and compare a low FODMAP diet versus an added sugar elimination diet effectiveness on symptoms but also impact on microbiome and its metabolome.
What is the current status of trial NCT06057376?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-10-26. Estimated completion is 2026-02.
What conditions does trial NCT06057376 study?
This clinical trial studies the following conditions: Carbohydrate Intolerance.
What interventions are being tested in trial NCT06057376?
The interventions under investigation include: Low-FODMAP diet group (LFD) (OTHER), Low Sugar diet group (LAS) (OTHER).
Who is sponsoring clinical trial NCT06057376?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06057376 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06057376's enrollment target sits among peer trials
40 1448th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI